Anti-SIRPa antibodies and their therapeutic applications
US11279766B2 · kind B2 · utility
2Cited by
0References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2017 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Mar 20, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides new anti-SIRPa antibodies able to specifically antagonize the interaction between SIRPa and CD47, without affecting the interaction between SIRPg and CD47, and their uses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.